Meet Arc’s Advisory Boards
Arc’s Scientific Advisory Board
Dr. Carolyn Bertozzi, Ph.D.
Dr. Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology, and an Investigator of the Howard Hughes Medical Institute at Stanford University. Her research focuses on translational chemical biology with particular applications in glycoscience, leading to the development of new diagnostic and therapeutic approaches. In 2022, Dr. Bertozzi was awarded the Nobel Prize in Chemistry for her invention of the field of bioorthogonal chemistry, which allows researchers to study molecules in living things without interfering with natural biological processes. She is also a prolific entrepreneur and the co-founder of Redwood Bioscience, Enable Biosciences, Palleon Pharma, InterVenn Biosciences, OliLux Biosciences, and Lycia Therapeutics. Dr. Bertozzi is also an elected member of the National Academy of Sciences, the National Academy of Medicine and the National Academy of Engineering, as well as a Foreign Member of the Royal Society.
Dr. Aviv Regev, Ph.D.
Dr. Regev serves as the Executive Vice President and Head of Research and Early Development at Genentech (gRED), a member of the Roche Group, where she leads efforts in drug discovery and drug development. She is also the co-founding co-chair of the international Human Cell Atlas initiative. Dr. Regev pioneered the development of foundational experimental methods and computational algorithms in single-cell genomics, and is a leader in deciphering intra- and intercellular molecular circuits in cells and tissues. Previously, Dr. Regev served as a Professor of Biology at the Massachusetts Institute of Technology, Founding Director of the Klarman Cell Observatory, Co-Director of the Cell Circuits Program at the Broad Institute of MIT and Harvard, and Investigator at the Howard Hughes Medical Institute. Among other honors, Dr. Regev is an elected member of the National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, and an elected foreign member of the UK Royal Society.
Arc’s AI Advisory Board
Dr. Dave Burke, Ph.D.
Dr. Burke served as Arc’s first Chief Technology Officer before moving into a broader advisory role, drawing on his experience leading the Virtual Cell Initiative team behind STATE, STACK, and the Virtual Cell Challenge to now support the Institute’s AI infrastructure and computational strategy. He joined Arc after a decade leading Android engineering at Google, and prior to that served as CTO of Voxpilot. He received his BE and MEngSc in Electronic Engineering and his Ph.D. in Biomedical Engineering, all from University College Dublin, where his doctoral work focused on mathematical modeling of brain electrical activity.
Dr. Georges Harik, Ph.D.
Dr. Harik is an angel investor, independent researcher, and co-founder of humans&, focusing his work on machine learning, internet applications, and biotechnology. He was one of Google's first ten employees, where he co-developed the targeting technology behind AdSense. He later served as a Director at Google, overseeing product and strategy for early initiatives including Gmail, Google Talk, and Orkut. He also led Google's acquisition of Android. As an independent researcher, he authored Quiet-STaR, and as an angel investor and advisor he has backed and supported companies including Lambda and Deep Infra.